TRxADE HEALTH, Inc. (MEDS)

$0.3511

-0.03 (-7.36%)
Rating:
Recommendation:
-
Symbol MEDS
Price $0.3511
Beta 1.176
Volume Avg. 0.36M
Market Cap 3.272M
Shares () -
52 Week Range 0.271-3.47
1y Target Est -
DCF Unlevered MEDS DCF ->
DCF Levered MEDS LDCF ->
ROE -135.14% Strong Sell
ROA -71.04% Strong Sell
Operating Margin -
Debt / Equity 238.22% Strong Buy
P/E -
P/B 2.07 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest MEDS news


Mr. Surendra K. Ajjarapu
Healthcare
Pharmaceutical Retailers
NASDAQ Capital Market

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.